Proline rich-oligopeptides: Diverse mechanisms for antihypertensive action
dc.contributor.author | Morais, Katia L. P. [UNIFESP] | |
dc.contributor.author | Ianzer, Danielle | |
dc.contributor.author | Miranda, Jose Rodolfo R. [UNIFESP] | |
dc.contributor.author | Melo, Robson L. | |
dc.contributor.author | Guerreiro, Juliano R. | |
dc.contributor.author | Santos, Robson A. S. | |
dc.contributor.author | Ulrich, Henning | |
dc.contributor.author | Lameu, Claudiana | |
dc.contributor.institution | Inst Butantan | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Univ Fed Ouro Preto | |
dc.contributor.institution | Universidade de São Paulo (USP) | |
dc.contributor.institution | Universidade Federal de Minas Gerais (UFMG) | |
dc.date.accessioned | 2016-01-24T14:34:32Z | |
dc.date.available | 2016-01-24T14:34:32Z | |
dc.date.issued | 2013-10-01 | |
dc.description.abstract | Bradykinin-potentiating peptides from Bothrops jararaca (Bj) discovered in the early 1960s, were the first natural inhibitors of the angiotensin-converting enzyme (ACE). These peptides belong to a large family of snake venom proline-rich oligopeptides (PROs). One of these peptides, Bj-PRO-9a, was essential for defining ACE as effective drug target and development of captopril, an active site-directed inhibitor of ACE used worldwide for the treatment of human arterial hypertension. Recent experimental evidences demonstrated that cardiovascular effects exerted by different Bj-PROs are due to distinct mechanisms besides of ACE inhibition. in the present work, we have investigated the cardiovascular actions of four Bj-PROs, namely Bj-PRO-9a, -11e, -12b and -13a. Bj-PRO-9a acts upon ACE and BK activities to promote blood pressure reduction. Although the others Bj-PROs are also able to inhibit the ACE activity and to potentiate the BK effects, our results indicate that antihypertensive effect evoked by them involve new mechanisms. Bj-PRO-11e and Bj-PRO-12b involves induction of [Ca2+](i) transients by so far unknown receptor proteins. Moreover, we have suggested argininosuccinate synthetase and M3 muscarinic receptor as targets for cardiovascular effects elicited by Bj-PRO-13a. in summary, the herein reported results provide evidence that Bj-PRO-mediated effects are not restricted to ACE inhibition or potentiation of BK-induced effects and suggest different actions for each peptide for promoting arterial pressure reduction. the present study reveals the complexity of the effects exerted by Bj-PROs for cardiovascular control, opening avenues for the better understanding of blood pressure regulation and for the development of novel therapeutic approaches. (C) 2013 Elsevier Inc. All rights reserved. | en |
dc.description.affiliation | Inst Butantan, CAT Cepid, LETA, São Paulo, Brazil | |
dc.description.affiliation | Universidade Federal de São Paulo, Dept Bioquim, São Paulo, Brazil | |
dc.description.affiliation | Univ Fed Ouro Preto, Dept Ciencias Biol, Inst Ciencias Exatas & Biol, Ouro Preto, MG, Brazil | |
dc.description.affiliation | Univ São Paulo, ESALQ, Dept Ciencias Biol, Lab Bioquim Prot,Ctr Biotecnol Agr CEBTEC, São Paulo, Brazil | |
dc.description.affiliation | Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Hipertensao, Belo Horizonte, MG, Brazil | |
dc.description.affiliation | Univ São Paulo, Inst Quim, Dept Bioquim, BR-05508900 São Paulo, Brazil | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Dept Bioquim, São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.format.extent | 124-133 | |
dc.identifier | http://dx.doi.org/10.1016/j.peptides.2013.07.016 | |
dc.identifier.citation | Peptides. New York: Elsevier B.V., v. 48, p. 124-133, 2013. | |
dc.identifier.doi | 10.1016/j.peptides.2013.07.016 | |
dc.identifier.issn | 0196-9781 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/36838 | |
dc.identifier.wos | WOS:000324998300016 | |
dc.language.iso | eng | |
dc.publisher | Elsevier B.V. | |
dc.relation.ispartof | Peptides | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.license | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
dc.subject | Proline-rich oligopeptides | en |
dc.subject | Argininosuccinate synthetase | en |
dc.subject | Muscarinic acetylcholine receptor | en |
dc.subject | Nitric oxide | en |
dc.subject | Mean arterial pressure | en |
dc.subject | Heart rate | en |
dc.title | Proline rich-oligopeptides: Diverse mechanisms for antihypertensive action | en |
dc.type | info:eu-repo/semantics/article |